MAYO, T.; ARMSTRONG, A.; KIRCIK, L.; SILVERBERG, J.; BLAUVELT, A.; ESDAILE, B.; SCHNEIDER, S.; MARK, T.; GOODERHAM, M.; ALEXIS, A. Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s144, 2023. DOI: 10.25251/skin.7.supp.144. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2025. Acesso em: 3 jul. 2024.